UNSPSC 51373432: Chlorpheniramine/hydrocodone/phenindamine/phenylephrine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373432 Chlorpheniramine/hydrocodone/phenindamine/phenylephrine/pyrilamine is a Commodity code under which state and local governments procure specialized pharmaceutical products and related services for healthcare delivery to specific populations in correctional and community health settings. Recent solicitations show procurement focused on parenteral pharmaceutical solutions—including intravenous nutrition preparations, controlled substances, and emergency medical products such as naloxone—rather than the specific branded combination named in the code itself. State and local issuing bodies using this code include state departments of corrections and county health departments. The Washington State Department of Corrections and Seminole County, Florida both solicited under or adjacent to this code in the recent period, suggesting activity among state correctional systems and county public health authorities.

Washington State Department of Corrections posted RFQ RFQQK13020 on September 8, 2026, seeking parenteral products, services, and equipment for supply to eight correctional facilities across the state, with a response deadline of October 7, 2026. The scope includes parenteral nutrition solutions (TPN and PPN), intravenous solutions, and other parenteral products including controlled substances, with delivery requirements of 24 hours for PN bags and 8 hours for other products. The contract runs from November 26, 2026 through June 30, 2030, with fixed pricing for the initial two-year term and DOC anticipating awards to multiple contractors. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building; the original response date listed in the source (July 26, 2023) predates the posting date and appears to be a data error. Both jurisdictions impose insurance and compliance requirements, with Washington State setting specific set-aside goals for small business, minority-owned, women-owned, and veteran-owned enterprises.